Omnicell, Inc. OMCL

Full chart Compare
Set alert

Price alert · OMCL

All alert types
39.41 USD +3.95 (+11.14%)

At closeNov 5, 2026, 7:52 AM EST

40.00 +0.59 +1.50%

Pre-market · Nov 5, 7:52 AM ET

36.54 Day range 39.63
31.75 52-week range 55.00
YTD
-13.00%
1 year
+10.27%
Market cap
1.79B
Revenue (ttm)
1.24B
Profit margin
3.59%
EPS (ttm)
0.96
Shares out
45.48M
P/E ratio
41.05
Forward P/E
19.62
YTD return
-13.00%
1-year return
+10.27%
Volume
850.49K
Avg volume
594.23K
Open
36.54
Previous close
35.46
Day's range
36.54 – 39.63
52-week range
31.75 – 55.00
Beta
0.89
Analysts
Strong Buy
Price target
57.43 (+45.7%)
Earnings date
Feb 4, 2027

2Y -10.39 (-20.86%)

304050Jan 25Jun 25Nov 25Apr 26Aug 2639.41

Key statistics

Enterprise value
1.50B
PEG ratio
15.40
Price / sales
1.44
Price / book
1.37
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
-0.90%
Free cash flow
155.97M
Total cash
314.86M
Total debt
189.67M
Return on equity
3.52%
Short % of float
8.68%
50-day average
34.64
200-day average
38.89

Financials — quick view

All financials
OMCL Revenue — quarterly 312.21M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
OMCL Net income — quarterly 24.29M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
OMCL EPS — quarterly 0.53
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

OMCL recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 4, 2027Dec 30, 20260.4213———
Oct 29, 2026Sep 30, 20260.41750.58+0.16+38.92%
Jul 30, 2026Jun 30, 20260.46750.94+0.47+101.07%
Apr 28, 2026Mar 31, 20260.330.55+0.22+66.67%
Feb 5, 2026Dec 31, 20250.470.40-0.07-14.89%
Oct 30, 2025Sep 30, 20250.360.51+0.15+41.67%

Upgrades / downgrades

OMCL analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026Freedom Capital MarketsmainBuyBuy
Aug 3, 2026Piper SandlerreitOverweightOverweight
Jul 31, 2026Wells FargomainOverweightOverweight
Jul 31, 2026KeybancmainOverweightOverweight
Apr 29, 2026KeybancmainOverweightOverweight
Apr 23, 2026Wells FargomainOverweightOverweight

About Omnicell, Inc.

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Sector
Healthcare
Industry
Health Information Services
Country
United States
Website
omnicell.com

News

Your note

Sign in to keep a note on OMCL — it syncs with the Stock Master app.

Insider holders

OMCL insider holders
InsiderRelationLatest transactionDateShares held
BAUER JOANNE BDirectorStock Award(Grant)May 31, 202649,922
ETTA NCHACHAChief Financial OfficerStock Award(Grant)Mar 6, 2025132,023
LIPPS RANDALL AChief Executive OfficerSaleJul 14, 20260
MANLEY COREY JOfficerSaleMay 17, 2026112,783
NJOKU NNAMDIPresidentSaleAug 16, 2026161,224
NUTT BRIAN HOfficerStock Award(Grant)Mar 31, 202623,085

Institution ownership

OMCL institution ownership
Holder% heldSharesValueReported
Blackrock Inc.16.58%7,539,602297.14MJun 29, 2026
Vanguard Portfolio Management LLC6.93%3,151,350124.19MJun 29, 2026
Wellington Management Group, LLP5.94%2,700,603106.43MJun 29, 2026
Dimensional Fund Advisors LP5.39%2,452,44396.65MJun 29, 2026
State Street Corporation4.59%2,085,72382.20MJun 29, 2026
Vanguard Capital Management LLC4.33%1,970,47277.66MJun 29, 2026

Fund ownership

OMCL fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.97%2,714,312106.97MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.01%1,368,38653.93MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.60%1,181,61346.57MSep 29, 2026
Delaware Group Equity Funds V-Nomura Small Cap Core Fund2.56%1,162,43745.81MAug 30, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.18%989,97539.01MJun 29, 2026
American Century Mutual Funds, Inc.-Small Cap Growth Fund1.43%649,08125.58MSep 29, 2026